Safety and Feasibility of Elective High-Risk Percutaneous Coronary Intervention Procedures With Left Ventricular Support of the Impella Recover LP 2.5

This publication has 10 references indexed in Scilit:

• Percutaneous left ventricular assist device: “TandemHeart” for high-risk coronary intervention
  Catheterization and Cardiovascular Interventions, 2005
• Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous impella recover LP 2.5 assist device during high‐risk coronary intervention
  Catheterization and Cardiovascular Interventions, 2005
• Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump
  The Journal of Heart and Lung Transplantation, 2005
• Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock
  European Heart Journal, 2005
• The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study
  European Heart Journal, 2005
• The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience
  The Journal of Thoracic and Cardiovascular Surgery, 2004
• Initial Experiences with the Impella Device in Patients with Cardiogenic Shock
  The Thoracic and Cardiovascular Surgeon, 2003
• Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty
  American Heart Journal, 2003
• A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction
  Published by Oxford University Press (OUP) ,1999
• A Prospective, Randomized Evaluation of Prophylactic Intraaortic Balloon Counterpulsation in High Risk Patients With Acute Myocardial Infarction Treated With Primary Angioplasty fn1fn1Funding for this study was provided in part by unrestricted grants from Advanced Cardiovascular Systems, Inc., Santa Clara, California; Mallinkrodt Medical, Inc., Saint Louis, Missouri; Datascope Corporation, Montvale, New Jersey; St. Jude Medical, Chelmsford, Massachusetts; and Siemens Corporation, Iselin, New Jersey.
  Journal of the American College of Cardiology, 1997